(l). The Borrower has not changed its name (whether by amendment of its certificate of formation, by reorganization or otherwise) or its jurisdiction of organization and has not changed its location within the four (4) months preceding the Closing Date.
(l). Section 7.02(l) of the Existing Credit Agreement is hereby amended in its entirety to read as follows:
(l). (h) the conversion of Class A Units (as defined in the US Borrower Partnership Agreement) into common Equity Interests of the US Borrower in accordance with the terms set forth in the US Borrower Partnership Agreement, (i) transactions pursuant to the Development Transactions, (j) transactions approved by the conflicts committee of the General Partner in good faith in accordance with the US Borrower Partnership Agreement and (k) the SPE Transactions.
(l). Schedule 1.1(l) of the Program Agreement is hereby amended by replacing such Schedule in its entirety with Schedule 1.1(l) attached hereto.
(l). Section 4(l) of the Agreement is hereby amended to read in its entirety as follows:
(l). Section III(L) shall have the following added to the end of such Section: If Physician is not selected to participate in the MA Plan, VIVA Health will provide written notice to the Physician of the reason for the denial.
(l). Section 9.05(l) is hereby amended and restated in its entirety to read as follows:
(l). Clauses (1) and (2) of Section 5.1(l) of the Purchase Agreement are hereby amended by replacing such clauses in their entirety as follows:
(l). As of the date of this Agreement, the Company is deemed Insolvent (as defined in the Securities Purchase Agreement).
(l). This Section 3.1(l) shall not apply to the following Company Stock Option
